Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis

Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis

<p dir="ltr">The main aim of this study is to compare the 2 medications denosumab and zoledronic acid for patients with beta-thalassemia major induced osteoporosis. Patients with B-thalassemia major induced osteoporosis will undergo baseline assessment of the bone densitometry by bon...

Full description

Saved in:
Bibliographic Details
Main Author: Mohamed A. Yassin (16322749) (author)
Other Authors: Mohamed O. Abdel Rahman (16555786) (author), Anas A. Hamad (16515247) (author), Abdul Razzakh Poil (16555788) (author), Mohamed T. Abdelrazek (16555791) (author), Radwa M. Hussein (16515249) (author), Nancy A. Kassem (16555795) (author), Afraa M. Fadul (16555796) (author), Sarah A. Elkourashy (16555798) (author), Abdulqadir J. Nashwan (16328993) (author)
Published: 2020
Subjects:
Biomedical and clinical sciences
Clinical sciences
Oncology and carcinogenesis
beta-thalassemia major
denosumab
osteoporosis
zoledronic acid
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items